24 /100
LOW RISK
Score updated May 29, 2026

FNCHQ — Finch Therapeutics Group, Inc. Dilution Risk Tracker

Track FNCHQ dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FNCHQ — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
40
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for FNCHQ.
🔔 Track FNCHQ — Get forecast alerts →

💹 Market Data

Market Cap$11.96M
Shares Outstanding1.61M
Float1.56M
Cash$16.04M
Debt$28.99M
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest393
Days to Cover1.0
% of Float0.0%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track FNCHQ Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FNCHQ — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADM
🔬 More Research for FNCHQ
📊 FNCHQ FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 FNCHQ Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.